China Law Key Words · 01 Practice
Product Liability
Practical China law orientation, guides and related counsel
139 articles · Latest update 13 Sep 2026
Reading on this topic
Guides, answers and analysis related to this topic.
139 articles
-
13 Aug 2026
CPL Article 55 Fraud and Professional Claimants in China
CPL Art. 55 fraud (3×, minimum RMB 500) is not the same as Art. 24 quality failure. Professional claimants (知假买假) live in that gap. FlagshipCPL map Ch.1 ChannelGT vs CBEC Ch.2 Pun…
-
13 Aug 2026
China B2C Jurisdiction and 2025 Prepaid Consumption Rules
Boilerplate global B2C terms and prepaid cards are two of the sharpest 2025–2026 exposures for foreign brands and franchisors. FlagshipCPL map Ch.1 ChannelGT vs CBEC Ch.2 Punitive…
-
13 Aug 2026
China 12315 and SAMR Consumer Dispute Response SOP
CCA mediation and a 12315/SAMR report are different legal animals. Withdrawal ends one and not the other. FlagshipCPL map Ch.1 ChannelGT vs CBEC Ch.2 PunitiveFSL 148 / CPL 55 Ch.3…
-
13 Aug 2026
China Consumer Compliance Indemnification Playbook
Onshore companies pay consumers first. Upstream recovery is a contract problem you must draft before the first shipment. FlagshipCPL map Ch.1 ChannelGT vs CBEC Ch.2 PunitiveFSL 14…
-
07 Aug 2026
Internet Hospitals & Digital Health Advertising in China: Compliance Orientation
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
Life Sciences & Healthcare China Compliance Checklist for CLO/CCO Teams
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
SaMD & AI Medical Software in China: Registration Path, Algorithm Governance & Liability
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
Drug Labeling, ADR Liability & Black Box / Boxed Warnings in China
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
Implant & Medical Device Product Liability in China: Malpractice vs Product Defect
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
Life Sciences & Healthcare Legal Issues in China: Compliance Cluster Hub
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
07 Aug 2026
Life Sciences & Healthcare in China: Key Laws and Primary Sources
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
02 Aug 2026
Medical Device Advertising and Promotion in China: Practical Guide
Marketing teams ask: Can we claim this device is “best-in-class,” run a KOL livestream, or post clinical data on WeChat? China regulates medical device advertising and promotion t…
-
02 Aug 2026
Pharmaceutical Advertising and Promotion in China: Practical Compliance Guide
General information only. Life sciences regulation in China spans NMPA product rules, PIPL/data security, human genetic resources, anti-corruption, volume-based procurement, IP, a…
-
02 Aug 2026
Online Lending and Consumer Finance in China: Regulatory Orientation
Product teams ask: Can we lend under our own brand app, or must we only provide technology to a bank? China tightened online lending after earlier excesses. This orientation helps…
-
02 Aug 2026
Industrial Robot Safety and Product Liability in China: Orientation
When an industrial robot cell injures a worker or damages property in China, responsibility cannot be allocated from the robot brand alone. The investigation normally needs to sep…
When the next step needs advice
Turn the legal issue into an actionable next step with guidance from a qualified lawyer.